Ovarian neoplasm
MONDO:0021068A benign, borderline, or malignant neoplasm involving the ovary.
Also known as: neoplasm of ovary, neoplasm of the ovary, ovarian neoplasm, ovarian tumor, ovarian tumors, ovarian tumour, ovarian tumours, ovary neoplasm
2516 clinical trials for this condition and its sub-types, 78 tagged with Ovarian neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ovarian neoplasm
-
Ovarian cancer 1,004 trials · 1,200 incl. sub-types
11 sub-types
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Malignant non-epithelial tumor of ovary 1 trial · 9 incl. sub-types Sub-types →
- Familial ovarian cancer 1 trial · 8 incl. sub-types Sub-types →
- Ovarian neuroendocrine neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Ovarian sarcoma 0 trials · 2 incl. sub-types Sub-types →
- Malignant ovarian cyst 1 trial
- Ovarian Wilms tumor 0 trials
- Ovarian adenosarcoma 0 trials
- Ovarian endometrioid adenocarcinofibroma 0 trials
- Ovarian lymphoma 0 trials
- Ovarian malignant mesothelioma 0 trials
-
Ovarian epithelial tumor 14 trials · 664 incl. sub-types
11 sub-types
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Ovarian serous tumor 6 trials · 208 incl. sub-types Sub-types →
- Ovarian clear cell tumor 7 trials · 57 incl. sub-types Sub-types →
- Borderline epithelial tumor of ovary 6 trials · 16 incl. sub-types Sub-types →
- Ovarian mucinous neoplasm 1 trial · 16 incl. sub-types Sub-types →
- Ovarian seromucinous tumor 1 trial · 14 incl. sub-types Sub-types →
- Ovarian Brenner tumor 3 trials · 5 incl. sub-types Sub-types →
- Ovarian papillary tumor 0 trials · 2 incl. sub-types Sub-types →
- Ovarian squamous cell neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Ovarian adenoma benign 0 trials Sub-types →
- Ovarian mucinous adenofibroma 0 trials Sub-types →
-
Ovarian germ cell tumor 9 trials · 13 incl. sub-types
4 sub-types
- Malignant germ cell tumor of ovary 2 trials · 4 incl. sub-types Sub-types →
- Ovarian teratoma 0 trials · 3 incl. sub-types Sub-types →
- Pediatric ovarian germ cell tumor 0 trials · 2 incl. sub-types Sub-types →
- Ovarian cystic teratoma 0 trials Sub-types →
-
Ovarian sex cord-stromal tumor 1 trial · 7 incl. sub-types
6 sub-types
- Malignant sex cord stromal tumor of ovary 0 trials · 5 incl. sub-types Sub-types →
- Ovarian granulosa cell tumor 2 trials · 5 incl. sub-types Sub-types →
- Ovarian sertoli-stromal cell tumor 0 trials · 1 incl. sub-types Sub-types →
- Benign ovarian sex cord-stromal tumor 0 trials Sub-types →
- Ovarian gynandroblastoma 0 trials
- Ovarian thecoma 0 trials
-
Ovarian benign neoplasm 1 trial
15 sub-types
- Meigs syndrome 0 trials
- Atypical Meigs syndrome 0 trials
- Benign ovarian mucinous tumor 0 trials
- Benign ovarian sex cord-stromal tumor 0 trials Sub-types →
- Benign struma ovarii 0 trials
- Ovarian adenoma benign 0 trials Sub-types →
- Ovarian clear cell adenofibroma 0 trials Sub-types →
- Ovarian endometrioid adenofibroma 0 trials Sub-types →
- Ovarian fibroma 0 trials
- Ovarian mucinous adenofibroma 0 trials Sub-types →
- Ovarian serous adenofibroma 0 trials Sub-types →
- Ovarian surface papilloma 0 trials
- Pseudo-Meigs syndrome 0 trials
- Rete ovarii cystadenofibroma 0 trials
- Serous or mucinous cystadenoma of childhood 0 trials Sub-types →
-
Ovarian melanoma 0 trials
-
Rete ovarii neoplasm 0 trials
3 sub-types
- Rete ovarii adenocarcinoma 0 trials
- Rete ovarii adenoma 0 trials Sub-types →
- Rete ovarii cystadenofibroma 0 trials
Most studied deeper sub-types
-
Engineered immune cells take aim at Mesothelin-Positive tumors
Disease control Stopped earlyThis trial tests a new cell therapy called TC-510 for people with advanced cancers that have a protein called mesothelin on their surface, including mesothelioma, ovarian cancer, and pancreatic cancer. TC-510 uses a patient's own immune cells, which are genetically modified to be…
Phase 1/2 • Sponsor: TCR2 Therapeutics • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Experimental cancer drug tested in early trial, but study stopped early
Disease control Stopped earlyThis early-stage trial tested an experimental drug called PF-08052666 in 19 people with advanced solid tumors like lung, ovarian, and pancreatic cancers that had not responded to standard treatments. The drug is designed to target and kill cancer cells. The study aimed to find a …
Phase 1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New cancer drug trial halted early – what we know
Disease control Stopped earlyThis study tested a new drug, felmetatug vedotin, alone or with pembrolizumab, in people with advanced solid tumors like ovarian, breast, and lung cancer. The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.
Phase 1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Ovarian cancer drug trial halted early: what happened?
Disease control Stopped earlyThis study aimed to see if the drug niraparib works better than standard chemotherapy before surgery for people with a specific type of advanced ovarian cancer (stage III or IV with HRd). The trial was planned for 36 participants but was stopped early. Researchers wanted to measu…
Phase 2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New pill targets Hard-to-Treat cancers in early human test
Disease control Stopped earlyThis early-phase trial tested an experimental oral drug called NKT3447 in 23 adults with advanced or metastatic solid tumors that had stopped responding to standard treatments. The goal was to check safety, find the right dose, and see if the drug could shrink tumors. The study w…
Phase 1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Pee test could replace pap smear for some women
Diagnosis Stopped earlyThis study tested whether offering a home urine test for human papillomavirus (HPV) could encourage more women to get screened for cervical cancer. The trial targeted women aged 30–65 in Brittany, France, who had not responded to an initial invitation for a Pap smear. Participant…
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC